Pharmaceutical Technology Europe, Jul 1, 2011 - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Pharmaceutical Technology Europe, Jul 1, 2011
News
News
By Stephanie Sutton
The coming years will show a slowing growth rate in the global spending of medicines, particularly when it comes to branded products.
Supply Chain
Degradation And What It Means To The Supply Chain
By Duane Sword
Product degradation is often overlooked compared with other supply chain issues, but if left unchecked can lead to the market entry of substandard medicines, whether through ignorance or gross negligence.
Industry Insider
Swiss Pharma Strength
By Nathan Jessop
Switzerland is an important power in Europe's pharmaceutical industry.
Manufacturing
Achieving Lean Processing With Single-Use Systems
By Vikas Gupta
Single-use filtration and fill–finish technologies can be used as part of a lean manufacturing strategy to boost production, and reduce manufacturing waste and costs.
Special Feature
The Decontamination Challenge
By James Drinkwater
The increase in aseptic processing driven by the growing number of biologically-derived products has led to an increase in freeze-drying applications in this area at both research and production scales.
Controlling Nucleation
By Mark Shon
Ideally, all product formulations should experience the same conditions when it comes to lyophilisation, but in practice, however, nucleation can occur.
Innovation And R&D In Freeze-Drying
By Isobel Cook
Lyophilisation or freeze-drying is widely used in the pharmaceutical industry for a variety of reasons.
Overcoming Common Lyophilization Scale-Up Issues
By Antonello Barresi
The same recipe obtained in laboratory-scale equipment cannot, without modifications, generally be used to freeze-dry the product in a pilot-scale or industrial-scale freeze-dryer.
Editor's Comment
Swiss, Please!
By Rich Whitworth
One of the perks of my job is that I can travel to previously unvisited cities. This month, I was lucky enough to be in Switzerland.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
23%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
7%
All of the above.
47%
No government involvement in patient treatment or drug development.
9%
Jim Miller Outsourcing Outlook Jim MillerOutside Looking In
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAdvances in Large-Scale Heterocyclic Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler New Era for Generic Drugs
Sean Milmo European Regulatory WatchSean MilmoTackling Drug Shortages
Click here